Tran H A
Hunter Area Pathology Service, John Hunter Hospital, Locked Bag Number 1, Hunter Mail Region Centre, New South Wales 2310, Australia.
South Med J. 2005 Jul;98(7):729-32. doi: 10.1097/01.smj.0000149407.51134.77.
Hyperkalemia is a potentially fatal condition and is defined by a serum potassium level (K+) of greater than 5.5 mmol/L. The associated prevalence of cardiac arrhythmia increases directly with the degree of hyperkalemia. The danger in the majority of hyperkalemia cases is cardiac dysrhythmia, and often ventricular fibrillation or asystole is the terminating event. Although there are many previous reports addressing this threatening problem and associated therapeutic maneuvers, there have not been many previous reports citing the fatal concentration of hyperkalemia irrespective of the causes. However, it is uniformly accepted that a K+ concentration greater than 10.0 mmol/L is fatal unless urgent treatment is instituted. This report describes a case of nonfatal hyperkalemia of 14 mmol/L with intact survival and complete recovery. Potassium homeostasis is revisited, and some explanations are proffered regarding the protective mechanism against hyperkalemia, including transcellular flux, renal tubular function, and endocrine responses.
高钾血症是一种可能致命的病症,其定义为血清钾水平(K+)大于5.5毫摩尔/升。心律失常的相关患病率随高钾血症的程度直接增加。大多数高钾血症病例的危险在于心脏节律失常,通常心室颤动或心搏停止是终末事件。尽管以前有许多报告论述了这个具有威胁性的问题及相关治疗措施,但以前很少有报告提及无论病因如何的高钾血症致死浓度。然而,人们一致认为,除非立即进行紧急治疗,K+浓度大于10.0毫摩尔/升是致命的。本报告描述了一例血清钾浓度达14毫摩尔/升的非致命性高钾血症病例,患者存活且完全康复。本文重新探讨了钾稳态,并对针对高钾血症的保护机制提出了一些解释,包括跨细胞转运、肾小管功能和内分泌反应。